The largest community of pharma leaders

Luca Dezzani

Top 10 Pharma Companies for R&D 1997 – 2017

R&D spending of pharmaceutical companies is often taken into consideration to understand the potential of future pipeline development. The animation provides you with an overview...

CRISPR Therapy 2017

Global Genome Editing Market The global genome editing market in 2016 is estimated at USD 2.84 Billion and forecasted to grow at a CAGR of...

Top 10 Oncology Drugs 1997 – 2017

Major pharmaceutical companies have invested immense resources into developing innovative treatments for cancer. Since 1997 the list of the best selling oncology drugs has evolved...

Top 20 Diabetes Drugs 2017

In 2016, global diabetes drugs market was valued at USD 30.95 billions and is estimated to grow by 7.5% to reach USD 44.53 billions...

Top 10 Pharmaceutical Companies 2017: Anti-Virals

Widespread infections caused by viruses are commonly known as viral diseases. Common types of viral diseases include cold, influenza, chickenpox, HIV/AIDS, viral hepatitis, HPV,...

PARP Inhibitors 2017

Poly (ADP-ribose) polymerase (PARP) inhibitors are targeted therapies that are used for multiple indications, most commonly, cancer. PARP aids in cellular growth, regulation and...

Good Forecasting: Fortune Telling or Systematic Predictions

What’s a forecast? Forecasting in the pharmaceutical industry may be viewed as a means of predicting the future, a tool that aids in decision making,...

Top 25 Rheumatology Drugs 2017

Rheumatology drug market is a highly consolidated market with the top ten players accounting for nearly 90% of the market share. The market is...

Top 5 Pharmaceutical Companies 2017: Vaccines

Vaccines are one of the most cost effective and powerful health interventions available. Billions of people from around the world are successfully being protected...

Cost of Cancer Drugs: R&D Spending vs Revenues

Cost of drugs has been matter of debate in recent years. It is often said that R&D costs to develop new medications are extremely...

Top 10 Pharmaceutical Companies 2017: Anti-Diabetics

Diabetes Mellitus is a physical condition associated with high blood sugar. It can have long-term detrimental effects on the blood vessels, heart, kidneys, eyes,...

Cost of Medicines in Context

Published on April 9, 2017 Innovations in the pharmaceutical and biotech industry are bringing amazing changes in the lives of the common people. Debilitating diseases, like...

Recent Featured Articles

Critical challenges that Physicians are facing during the Pandemic

In September 2019, Fine Research a consultancy firm specialized in Healthcare Online and Qual data collection in LatAm, began an unprecedented study in the...

Working with, Advocating for, and Empowering Patients

A version of this article was previously published on Pharmaphorum. In recent years, there has been a clear shift in Pharma when it comes to...

Medical Affairs and Stakeholder Engagement in an Evolving Healthcare Scenario

Due to unprecedented challenging situation and the current pandemic time, stakeholders needs are changing and these uncertain times are accelerating approaches already existing within...

“Fake News” and Credibility in Medical Publishing

A version of this article was previously published on Pharmaphorum. Doubtlessly, one of the defining phrases of the 2010s is “fake news.” We hear it...

Top 10 Most Important Advisor Questions

Today, I would like to share the top 10 most important advisor questions that every brand team should keep in mind when designing virtual advisory board...